KLEMP WALTER V — SEC insider filings
SEC reporting owner CIK 938419. 38 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 38 filings on record, filed 2021-04-16 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 6 filings — 1,574,867 shares, $571,367 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 102.
- Largest priced transaction: purchase of 675,675 shares @ $0.37 ($250,000) in Moleculin Biotech, Inc., filed 2025-06-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Moleculin Biotech, Inc. (MBRX) | CEO and President, Director | 33 | 7 legs · 1,574,867 sh · $571,367 | — | 89 |
| Soliton, Inc. (SOLY) | Executive Chairman, Director | 2 | — | — | 10 |
| Autonomix Medical, Inc. (AMIX) | Director | 3 | — | — | 3 |
Insider filings — KLEMP WALTER V
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 577 · Tax withholding (F): 141 @ $7.41 · Option exercise (M): 577 (derivative) @ $0 | EDGAR |
| 2026-11-06 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 57 · Tax withholding (F): 14 @ $8.46 · Option exercise (M): 57 (derivative) @ $0 | EDGAR |
| 2026-10-16 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 207,500 · Tax withholding (F): 48,659 @ $0.37 · Grant/award (A): 415,000 (derivative) · Grant/award (A): 415,000 (derivative) · Option exercise (M): 207,500 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Autonomix Medical, Inc. (AMIX) | Grant/award (A): 13,000 | EDGAR |
| 2026-08-05 | 4 | Moleculin Biotech, Inc. (MBRX) | Purchase (P): 533,333 · Grant/award (A): 1,599,999 (derivative) | EDGAR |
| 2026-06-24 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 150 · Tax withholding (F): 37 @ $2.88 · Option exercise (M): 360 · Tax withholding (F): 88 @ $3.12 · Option exercise (M): 150 (derivative) @ $0 · Option exercise (M): 360 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | Moleculin Biotech, Inc. (MBRX) | Grant/award (A): 830,000 (derivative) · Grant/award (A): 750,000 (derivative) | EDGAR |
| 2025-11-06 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 28,750 · Tax withholding (F): 7,001 @ $0.50 · Option exercise (M): 28,750 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Autonomix Medical, Inc. (AMIX) | Disposition to issuer (D): 8,773 (derivative) | EDGAR |
| 2025-06-23 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 3,750 · Tax withholding (F): 914 @ $0.27 · Option exercise (M): 8,990 · Tax withholding (F): 2,190 @ $0.27 · Purchase (P): 675,675 @ $0.37 · Option exercise (M): 3,750 (derivative) @ $0 · +2 more | EDGAR |
| 2025-06-18 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 1,667 · Tax withholding (F): 406 @ $0.69 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2024-11-06 | 4 | Moleculin Biotech, Inc. (MBRX) | Grant/award (A): 100,000 (derivative) · Grant/award (A): 115,000 (derivative) · Grant/award (A): 43,590 (derivative) | EDGAR |
| 2024-07-05 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 982 · Tax withholding (F): 240 @ $3.57 · Option exercise (M): 982 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 8,990 · Tax withholding (F): 2,190 @ $3.74 · Option exercise (M): 8,990 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Autonomix Medical, Inc. (AMIX) | Grant/award (A): 175,452 (derivative) | EDGAR |
| 2024-06-21 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 3,750 · Tax withholding (F): 914 @ $3.78 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 1,667 · Tax withholding (F): 406 @ $4.14 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2023-12-27 | 4 | Moleculin Biotech, Inc. (MBRX) | Purchase (P): 188,404 @ $0.69 | EDGAR |
| 2023-07-13 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 13,204 · Tax withholding (F): 3,216 @ $0.59 · Option exercise (M): 13,204 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 14,717 · Tax withholding (F): 3,584 @ $0.58 · Option exercise (M): 14,717 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Moleculin Biotech, Inc. (MBRX) | Grant/award (A): 400,000 (derivative) · Grant/award (A): 539,375 (derivative) | EDGAR |
| 2023-06-22 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 56,250 · Tax withholding (F): 13,697 @ $0.57 · Option exercise (M): 56,250 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 25,000 · Tax withholding (F): 6,088 @ $0.57 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2022-11-28 | 4 | Moleculin Biotech, Inc. (MBRX) | Purchase (P): 45,000 @ $1.28 | EDGAR |
| 2022-11-23 | 4 | Moleculin Biotech, Inc. (MBRX) | Purchase (P): 22,500 @ $1.15 | EDGAR |
| 2022-11-18 | 4 | Moleculin Biotech, Inc. (MBRX) | Purchase (P): 85,213 @ $0.97 · Purchase (P): 24,742 @ $1.02 | EDGAR |
| 2022-07-15 | 4/A | Moleculin Biotech, Inc. (MBRX) | Grant/award (A): 225,000 (derivative) · Grant/award (A): 225,000 (derivative) | EDGAR |
| 2022-07-15 | 4/A | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 13,204 · Tax withholding (F): 3,215 @ $1.68 · Option exercise (M): 13,205 (derivative) @ $0 | EDGAR |
| 2022-07-15 | 4/A | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 14,717 · Tax withholding (F): 3,584 @ $1.47 · Option exercise (M): 14,717 (derivative) @ $0 | EDGAR |
| 2022-07-13 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 13,204 · Tax withholding (F): 3,215 @ $1.68 · Option exercise (M): 13,205 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 14,717 · Tax withholding (F): 3,584 @ $1.47 · Option exercise (M): 14,717 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Moleculin Biotech, Inc. (MBRX) | Grant/award (A): 360,000 (derivative) · Grant/award (A): 362,000 (derivative) | EDGAR |
| 2022-06-21 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 25,000 · Tax withholding (F): 6,088 @ $1.33 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Soliton, Inc. (SOLY) | Disposition to issuer (D): 425,000 @ $22.60 · Disposition to issuer (D): 725,000 (derivative) · Disposition to issuer (D): 84,500 (derivative) · Disposition to issuer (D): 35,150 (derivative) · Disposition to issuer (D): 89,300 (derivative) · Disposition to issuer (D): 113,000 (derivative) · +3 more | EDGAR |
| 2021-07-12 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 13,205 · Tax withholding (F): 3,215 @ $3.56 · Option exercise (M): 13,205 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | Moleculin Biotech, Inc. (MBRX) | Option exercise (M): 14,718 · Tax withholding (F): 3,584 @ $3.56 · Option exercise (M): 14,718 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Moleculin Biotech, Inc. (MBRX) | Grant/award (A): 223,635 (derivative) · Grant/award (A): 100,000 (derivative) | EDGAR |
| 2021-04-16 | 4 | Soliton, Inc. (SOLY) | Grant/award (A): 113,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=938419 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs